Clinical Trial Update: Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating chemoembolization with or without antiviral therapy for unresectable HBV-related hepatocellular carcinoma with low HBV …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: UNKNOWN